Chemical and Pharmaceuticals industries are working with inefficient atom economy and throughput. In order to be cost effective and increase throughput, an advisory role has been initiated. The focus of Way Pharma is to improve the yield and minimize the byproduct generation and effluent load, which results profitability to the industry. With API regulations, pharmaceutical industry is rapidly changing. Keep up the pace with Way Pharma and get expert advise in making your drug pass through the inspection easily. Way Pharma has proven expertise of upscaling of API and intermediate. The excellence can be achieved in cost, quality and productivity via throughput improvement with consultation of Way Pharma. Managing Partner & CEO – Way Pharma 35 years of industrial experience in API Research and Development. Responsible for overall R&D activities including introduction of novel process for generic molecules, process optimization, impurity profiling, characterization of compounds, up scaling, technology transfer and regulatory filing. Ph. D. from Banaras Hindu University in Organic Chemistry. 35 years of industrial experience as API Research and Development and was Responsible for overall R&D activities including introduction of novel process for generic molecules, process optimization, impurity profiling, characterization of compounds, up scaling, technology transfer and regulatory filing. Published 9 research papers in international journals of repute and filed more than 300 Patents. Visit here to know more. Way Forward Request an Appointment Your information will be collected to analyse the matter and schedule the consulting time. For urgent matters, please call on the number below: Revolutionizing API Consultancy
Welcome to Way Pharma LLP
The Ultimate API Expertise You Need
Advisory For Cost Effective API Development
Adhering To API Regulations For Quality
Up-Scale The API & Intermediate
Spotlight Personage
Dr. S. P. D. Dwivedi
Know More
Education
Professional Experience
Publications
To develop cost effective API and Intermediates for regulated markets.